Asbt inhibitors in the treatment of renal diseases
US-2024207286-A1 · Jun 27, 2024 · US
US11098075B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11098075-B2 |
| Application number | US-201515510268-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 11, 2015 |
| Priority date | Sep 12, 2014 |
| Publication date | Aug 24, 2021 |
| Grant date | Aug 24, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a method for preparing 2′-O-fucosyllactose, the 2′-O-fucosyllactose obtainable by this method and the use thereof. The method comprises reacting the persilylated, protected fucose derivatives of the formula (I) below, with at least one tri(C1-C6-alkyl)silyl iodide and subsequently reacting the product thus obtained with the compound of the general formula (II), in the presence of a base.In the formulae (I) and (II), the variables are each defined as follows:RSi are the same or different and are a residue of the formula SiRaRbRc;R1 is a C(═O)—R11 residue or an SiR12R13R14 residue,R2 are the same or different and are C1-C8-alkyl or together form a linear C3-C6-alkanediyl, which is unsubstituted or has 1 to 6 methyl groups as substituents;R3 are the same or different and are C1-C8-alkyl or together form a linear C1-C4-alkanediyl, which is unsubstituted or has 1 to 6 methyl groups as substituents.
Opening claim text (preview).
The invention claimed is: 1. A method for preparing 2′-O-fucosyllactose, comprising: a) reacting protected fucose of formula (I) where each R S1 is the same or different and is a residue of the formula SiR a R b R c , where R a , R b and R c are the same or different and are selected from the group consisting of C 1 -C 8 -alkyl, C 3 -C 8 -cycloalkyl, phenyl and C 3 -C 8 -cycloalkyl-C 1 -C 4 -alkyl; with a compound of formula (II) where R 1 is a C(═O)—R 11 residue or an SiR 12 R 13 R 14 residue, in which R 11 is hydrogen, C 1 -C 8 -alkyl, C 1 -C 8 -haloalkyl, C 3 -C 8 -cycloalkyl, C 3 -C 8 -cycloalkyl-C 1 -C 4 -alkyl or phenyl, wherein said phenyl is unsubstituted or has 1 to 5 substituents selected from the group consisting of halogen, CN, NO 2 , C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -haloalkyl and C 1 -C 4 -haloalkoxy, and R 12 , R 13 and R 14 are the same or different and are selected from the group consisting of C 1 -C 8 -alkyl, C 3 -C 8 -cycloalkyl, phenyl and C 3 -C 8 -cycloalkyl-C 1 -C 4 -alkyl; R 2 is each the same or different and are C 1 -C 8 -alkyl or 2 R 2 residues attached to the same carbon atom together form a linear C 3 -C 6 -alkanediyl, which is unsubstituted or has 1 to 6 methyl groups as substituents; R 3 is each the same or different and are C 1 -C 8 -alkyl or together form a linear C 1 -C 4 -alkanediyl, which is unsubstituted or has 1 to 6 methyl groups as substituents; b) deprotecting the coupling product of the general formula (III) obtained in step a) where R Si , R 1 , R 2 and R 3 are as defined above; to obtain 2′-O-fucosyllactose; wherein step a) comprises a.1) treating the protected fucose of formula (I) with a tri(C 1 -C 6 -alkyl)silyl iodide a.2) reacting the product obtained in step a.1) with the compound of the formula (II) in the presence of at least one base; wherein the compound of formula (I) and the compound of formula (II) are reacted in a molar ratio (I):(II) in the range of 1:3 to 2:1. 2. The method according to claim 1 , wherein the tri(C 1 -C 6 -alkyl)silyl iodide is trimethylsilyl iodide. 3. The method according to claim 1 , wherein the tri(C 1 -C 6 -alkyl)silyl iodide is used in an amount of 0.8 to 1.4 mol per mole of the compound of the formula (I). 4. The method according to claim 1 , wherein the tri(C 1 -C 6 -alkyl)silyl iodide is generated in situ by treatment of the corresponding tri(C 1 -C 6 -alkyl)silyl chloride with an iodide salt. 5. The method according to claim 1 , where the tri(C 1 -C 6 -alkyl)silyl iodide is generated in situ by reacting the corresponding hexa(C 1 -C 6 -alkyl)disilane with iodine. 6. The method according to claim 5 , wherein, first, in step a.1) the hexa(C 1 -C 6 -alkyl)disilane is reacted with iodine and then the resulting reaction mixture is reacted with the compound of formula (I). 7. The method according to claim 1 , wherein in step a): a.1) the compound of the formula (I) is first treated with a tri(C 1 -C 6 -alkyl)silyl iodide and a.2) the resulting product is reacted without further purification with the compound of the formula (II) in the presence of the base. 8. The method according to claim 5 , wherein the base is used in at least an equimolar amount, based on the compound of the formula (I). 9. The method according to claim 5 , wherein the base comprises at least one basic compound, which is selected from amine bases. 10. The method according to claim 9 , wherein, the base additionally comprises a basic compound, which is selected from the group consisting of alkali carbonates, alkali hydrogen carbonate and mixtures thereof. 11. The method according to claim 10 , wherein, a.1) first, the hexa(C 1 -C 6 -alkyl)disilane is reacted with iodine and then the resulting reaction mixture is reacted with the compound of formula (I); a.2) the reaction mixture of step a.1) is treated with a basic compound, which is selected from the group consisting of alkali carbonates, alkali hydrogen carbonate and mixtures thereof, and the resulting mixture is subsequently reacted with the compound of formula (II) in the presence of an amine base. 12. The method according to claim 5 , wherein step a.2) takes place in the presence of at least one reagent selected from the group consisting of iodine, iodide salts and triarylphosphine oxides and mixtures thereof. 13. The method according to claim 1 , wherein in step b) b.1) the compound of the formula (III) is treated with water in the presence of an acid; or b.2) the compound of the formula (III), in which R 1 is an SiR 12 R 13 R 14 residue, is first treated with a desilylating reagent, wherein a compound of the formula (IIIb′) is obtained: and subsequently the remaining protecting groups are removed by treating the compound of the formula (IIIb′) with water in the presence of an acid; or b.3) the compound of the formula (III), in which R 1 is a C(O)R 11 residue, is first treated with a desilylating reagent, wherein a compound of the formula (IIIc′) is obtained: and subsequently the C(O)—R 11 group and the remaining protecting groups are successively removed; or b.4) the protecting groups C(R 2 ) 2 and OR 3 are first removed from the compound of the formula (III), in which R 1 is a C(O)R 11 residue, wherein a compound of the formula (IV) is obtained: and the C(O)—R 11 group is subsequently removed, or b.5) the compound of formula (III), wherein R 1 is a radical C(O)—R 11 , is first treated with a C 1 -C 4 -alkanol and an alkalimetal base, whereby a compound of formula (IIIb′) is obtained, and subsequently the remaining protecting groups are removed by treating the compound of the formula (IIIb′) under acidic reaction conditions. 14. The method according to claim 1 , wherein the R Si residue in formulae (I) and (III) is trimethylsilyl. 15. The method according to claim 1 , wherein the R 1 residue in formulae (II) and (III) is trimethylsilyl. 16. The method according to claim 1 , wherein the R 1 residue in formulae (II) and (III) is acetyl, pivaloyl or benzoyl. 17. The method according to claim 1 , wherein the R 2 residue in formulae (II) and (III) is methyl. 18. The method according to claim 1 , wherein the R 3 residue in formulae (II) and (III) is methyl. 19. A compound of formula (Ma) where R 1a is an SiR 12 R 13 R 14 residue residue, where R 12 , R 13 and R 14 are the same or different and are selected from the group consisting of C 1 -C 8 -alkyl, C 3 -C 8 -cycloalkyl, phenyl and C 3 -C 8 -cycloalkyl-C 1 -C 4 -alkyl; R 2 are the same or different and are C 1 -C 8 -alkyl or 2 R 2 residues attached to the same carbon a
Acyclic or carbocyclic radicals, substituted by hetero rings · CPC title
using additives (addition of substantially indigestible substances A23L33/21) · CPC title
Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages · CPC title
Processes for the preparation of sugar derivatives · CPC title
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.